| Home > Sell Offers > Epileptic Bulk Drugs |
Sreeven Pharma Private Limited (SPPL) is a 4 year old business-driven biopharma product commercialization company. Through selected entrepreneurial biopharma partner-scientists, SPPL nurtures knowledge-based technology demonstration and development projects. Currently, SPPL is developing products in the areas of respiratory distress therapeutics, FMCG biopharmaceuticals (cosmoceuticals, medical cements, formulations, delivery devices) and bulk pharma drugs and intermediates.
SPPL has built a schedule ‘M’ GMP standards dedicated facility for manufacturing bulk drugs and intermediates. The product mix was chosen to flexibly meet market demands. The "Smart Factory" co-processes and manufactures a minimum of two bulk drugs (and/or intermediates) simultaneously, depending upon market enquiries.